[1]白淑玮,毕春潮△,邵 娟,等.玻璃体切割手术联合全视网膜光凝术治疗糖尿病视网膜病变临床疗效观察*[J].陕西医学杂志,2020,49(12):1569-1572.[doi:DOI:10.3969/j.issn.1000-7377.2020.12.008]
　BAI Shuwei,BI Chunchao,SHAO Juan,et al.Clinical effect of pars plana vitrectomy combined with panretinal photocoagulation in treatment of diabetic retinopathy[J].,2020,49(12):1569-1572.[doi:DOI:10.3969/j.issn.1000-7377.2020.12.008]
点击复制

玻璃体切割手术联合全视网膜光凝术治疗糖尿病视网膜病变临床疗效观察*
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
49
期数:
2020年12期
页码:
1569-1572
栏目:
临床研究
出版日期:
2020-12-05

文章信息/Info

Title:
Clinical effect of pars plana vitrectomy combined with panretinal photocoagulation in treatment of diabetic retinopathy
作者:
白淑玮; 毕春潮△; 邵 娟; 周卓琳; 许治国
西安市第四医院(西安 710004)
Author(s):
BAI Shuwei; BI Chunchao; SHAO Juan; et al.
Xi'an No.4 Hospital(Xi'an 710004)
关键词:
玻璃体切割手术;  糖尿病视网膜病变;  视盘新生血管;  视网膜新生血管;  糖尿病黄斑水肿;  全视网膜光凝术
Keywords:
Pars plana vitrectomy;  Diabetic retinopathy;  Neovascularization of the disk;  Neovascularization elsewhere;  Diabetic macular edema;  Panretinal photocoagulation
分类号:
R587.2
DOI:
DOI:10.3969/j.issn.1000-7377.2020.12.008
文献标志码:
A
摘要:
目的:观察玻璃体切割手术(PPV)联合全视网膜光凝术(PRP)对糖尿病视网膜病变(DR)的临床疗效。方法:选取29例DR患者(29眼)作为研究对象,根据手术方法的不同分为PPV组(14例,14眼)和PRP组(15例,15眼)。PPV组给予PPV联合PRP治疗,PRP组给予单纯PRP治疗。随访2年后,比较两组患者术前与随访2年后最佳矫正视力(BCVA)以及糖尿病黄斑水肿(DME)、视盘新生血管(NVD)和视网膜新生血管(NVE)出现情况。结果:经过2年随访,PPV组患者BCVA优于PRP组,差异具有统计学意义(P<0.05)。PPV组视网膜前出血/玻璃体出血发生率低于PRP组,差异具有统计学意义(P=0.042)。PPV组随访2年后BCVA较术前轻度提高,但差异无统计学意义(P=0.102)。PRP组随访2年后BCVA较术前显著下降,差异具有统计学意义(P=0.006)。结论:对于NPDR和早期PDR,PPV联合PRP治疗可能维持患者现有视力,甚至提高患者视力,可以作为DR治疗的一种治疗选择。
Abstract:
Objective:To investigate the clinical effect of pars plana vitrectomy(PPV)combined with panretinal photocoagulation(PRP)in the treatment of diabetic retinopathy(DR).Methods:29 patients(29 eyes)with DR were selected and divided into PPV group(14 cases,14 eyes)and PRP group(15 cases,15 eyes)according to different surgical methods.PPV group was treated with PPV combined with PRP,and PRP group was treated with PRP alone.The best corrected visual acuity(BCVA),diabetic macular edema(DME),neovascularization of the disk(NVD)and neovascularization elsewhere(NVE)before surgery and after 2 years of follow-up were compared between the two groups.Results:After 2 years of follow-up,the BCVA in PPV group was better than that in PRP group(P<0.05).The incidence of preretinal hemorrhage/vitreous hemorrhage in PPV group was lower than that in PRP group(P=0.042).The BCVA in PPV group was increased slightly after 2 years of follow-up,but the difference was not statistically significant(P=0.102).The BCVA in PRP group was decreased significantly after 2 years of follow-up(P=0.006).Conclusion:For severe NPDR and early PDR,PPV combined with PRP may maintain the existing visual acuity of patients,and even improve their visual acuity,which can be used as a treatment option for DR.

参考文献/References:

[1] Bommer C,Sagalova V,Heesemann E,et al.Global economic burden of diabetes in adults:projections from 2015 to 2030[J].Diabetes Care,2018,41(5):963-970.
[2] 李春花,吴冠吉,惠 娜,等.糖尿病视网膜病变激光治疗后干眼治疗临床研究[J].陕西医学杂志,2018,47(2):156-158.
[3] 段俞伽,崔 硕,刘 旭.参芪降糖颗粒联合迈之灵治疗非增殖期2型糖尿病视网膜病变气阴两虚、络脉瘀阻证疗效研究[J].陕西中医,2020,41(3):334-337.
[4] 周 剑,杨晓晖.糖尿病视网膜病变的诊断与处理[J].中华全科医学,2017,15(4):550-551.
[5] Yang CM,Yeh PT,Yang CH.Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy[J].Ophthalmology,2007,114(4):710-715.
[6] Khan MA,Samara WA,Hsu J,et al.Short-term outcomes of hybrid 23-,25-,and 27-gauge vitrectomy for complex diabetic tractional retinal detachment repair[J].Retin Cases Brief Rep,2019,13(3):244-247.
[7] Yau GL,Silva PS,Arrigg PG,et al.Postoperative complications of pars plana vitrectomy for diabetic retinal disease[J].Semin Ophthalmol,2018,33(1):126-133.
[8] Kanclerz P,Pyrzanowska-Sumita J,Murawska J,et al.Vitreous hemorrhages in proliferative diabetic retinopathy treated with pars plana vitrectomy-own material[J].Klin Oczna,2013,115(4):291-295.
[9] Lee R,Wong TY,Sabanayagam C.Epidemiology of diabetic retinopathy,diabetic macular edema and related vision loss[J].Eye Vis,2015,2:17.
[10] Bain SC,Klufas MA,Ho A,et al.Worsening of diabetic retinopathy with rapid improvement in systemic glucose control:a review[J].Diabetes Obes Metab,2019,21(3):454-466.
[11] El Rami H,Barham R,Sun JK,et al.Evidence-based treatment of diabetic retinopathy[J].Semin Ophthalmol,2017,32:67-74.
[12] Jackson TL,Nicod E,Angelis A,et al.Pars plana vitrectomy for diabetic macular edema:a systematic review,meta-analysis,and synthesis of safety literature[J].Retina,2017,37(5):886-895.
[13] Nakajima T,Roggia MF,Noda Y,et al.Effect of internal limiting membrane peeling during vitrectomy for diabetic macular edema:systematic review and meta-analysis[J].Retina,2015,35(9):1719-1725.
[14] Youngblood H,Robinson R,Sharma A,et al.Proteomic biomarkers of retinal inflammation in diabetic retinopathy[J].International Journal of Molecular Sciences,2019,20(19):4755.
[15] Wu MY,Yiang GT,Lai TT,et al.The oxidative stress and mitochondrial dysfunction during the pathogenesis of diabetic retinopathy[J].Oxid Med Cell Longev,2018,2018:3420187.
[16] He M,Wang W,Yu H,et al.Comparison of expression profiling of circular RNAs in vitreous humour between diabetic retinopathy and non-diabetes mellitus patients[J].Acta Diabetol,2020,57(4):479-489.

相似文献/References:

[1]刘文强,刘学政,左中夫△.RU486通过Notch1/Hes-1信号通路对糖尿病大鼠视网膜神经节细胞的保护作用及机制研究*[J].陕西医学杂志,2020,49(6):656.[doi:DOI:10.3969/j.issn.10007377.2020.06.004]
　LIU Wenqiang,LIU Xuezheng,ZUO Zhongfu..Protective effect of RU486 on retinal ganglion cells in diabetic rats via Notch1/Hes-1 signaling pathway[J].,2020,49(12):656.[doi:DOI:10.3969/j.issn.10007377.2020.06.004]
[2]薛 涛,张娟娟,杜建英,等.内毒素通过干预大鼠玻璃体中晶状体蛋白家族蛋白表达影响视网膜电图波幅和玻璃体通透性机制研究[J].陕西医学杂志,2022,51(5):543.[doi:DOI:10.3969/j.issn.1000-7377.2022.05.007]
　XUE Tao,ZHANG Juanjuan,DU Jianying,et al.Mechanism of endotoxin affecting electroretinogram amplitude and vitreous permeability by interfering with expression of crystallin family proteins in rat vitreous[J].,2022,51(12):543.[doi:DOI:10.3969/j.issn.1000-7377.2022.05.007]
[3]孟 宏,王桂青,杜竹君.西红花苷通过调控TLR4/MyD88/NF-κB通路改善糖尿病大鼠视网膜病变机制研究[J].陕西医学杂志,2023,52(5):531.[doi:DOI:10.3969/j.issn.1000-7377.2023.05.008]
　MENG Hong,WANG Guiqing,DU Zhujun.Mechanism of crocin improving diabetic retinopathy by regulating TLR4/MyD88/NF-κB pathway in rats[J].,2023,52(12):531.[doi:DOI:10.3969/j.issn.1000-7377.2023.05.008]
[4]徐梓凡,郑昊涵,谢田华,等.环状RNA功能及与眼科相关疾病关系研究进展[J].陕西医学杂志,2023,52(5):626.[doi:DOI:10.3969/j.issn.1000-7377.2023.05.030]

备注/Memo

备注/Memo:
*国家自然科学基金资助项目(81302189)
更新日期/Last Update: 2020-12-11